~~<i id='B24E2D8FB7'><strike id='B24E2D8FB7'><tt id='B24E2D8FB7'><pre id='B24E2D8FB7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：hotspot 2025-08-23 08:55:00 - browse：9996

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Judge denies Trump's request for new trial in E. Jean Carroll case

explore

hotspot

focus

Wikipedia

knowledge

AfluvaccinesyringerestsonatableatavaccinationclinicinLakewood,Calif.MarioTama/GettyImagesWhenAmerica

WSS

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Telehealth startups are trying to fill the menopause care vacuum

For AI in health care standards, federal regulators join with industry group

Dementia risk linked to living in disadvantaged areas: Study

US jobless claims fall again as labor market continues to flash strength

Ozempic has benefits for kidney disease as well as diabetes

explore

Wikipedia

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A new ‘biological computer' targets cancer while sparing healthy cells

Heart attack and stroke risk calculators need revising

Stanford president’s abrupt resignation sparks debate

Medical records are filled with copy

Streamlined flu vaccines recommended by FDA advisory panel

ChatGPT in medicine: STAT answers readers' burning questions

Stem cell biologist probes earliest stages of human development

FDA approval of Sarepta Duchenne genetic therapy gives me hope

IVF doctors demand details after CooperSurgical lawsuit

hotspot

In rare move, senator releases unverified FBI source report alleging Biden bribe

The untold story of TV’s first prescription drug ad

State of the Union pitch: Bigger Medicare drug price negotiations

For AI in health care standards, federal regulators join with industry group

Are infertility treatments 'essential' during the Covid

Harvard's David Sinclair gets blowback over aging

focus

focus

Wikipedia

knowledge